PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
PVLA
71 hedge funds and large institutions have $115M invested in Palvella Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 19 closing their positions.
Holders
71
Holders Change
-10
Holders Change %
-12.35%
% of All Funds
1.12%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
9
Increased
24
Reduced
20
Closed
19
Calls
$591K
Puts
$68K
Net Calls
+$523K
Net Calls Change
-$272K
Top Buyers
Top Sellers
1 |
1
Two Sigma Investments
New York
|
$412K |
2 |
WP
2
Woodline Partners
San Francisco,
California
|
$4.81M |
3 |
3
Two Sigma Advisers
New York
|
$1.24M |
4 |
4
Millennium Management
New York
|
$2.16M |
5 |
5
Goldman Sachs
New York
|
$591K |